Kromek Share Discussion Threads

[chimers] 25/1/2017 07:11

No discount .

[trotterstrading] 25/1/2017 07:09

Hardly. No discount and NEW BLUE CHIP ii'sCashed up and ready for global scale up!

[toolsmoker] 23/1/2017 15:24

Think this needs finding to shore up balnce sheet once that is done then will start to rise Think this is the bottom we await news

[chimers] 23/1/2017 14:26

You just answered your own question.

DO NOTHING.

[bsharman3] 23/1/2017 14:22

I'm trying to work out if it's worth averaging down on this one or the downward spiral (in the share price) will continue.... It could be a cheap price - then again it could also be expensive!

[hannahh] 17/1/2017 14:10

A reminder that if you would like to hear Arnab Basu, CEO, present on behalf of Kromek he will be appearing at our next investor forum on the evening of Wednesday 25th of January. Also appearing will be the management of Ergomed and Realm Therapeutics.

To learn more about the forum and to register for free please follow this link: hxxps://www.eventbrite.co.uk/e/equity-development-investor-forum-january-2017-tickets-30349576400

Thanks,
The Equity Development team

[trotterstrading] 13/1/2017 12:32

Selling done?! Overhang clear? Let's see where this goes oversold IMO

[trotterstrading] 13/1/2017 11:45

See you there Ali. Looking forward the CEO's responses to some awkward questions

[quepassa] 12/1/2017 20:54

Remember guys, we've given them our capital to use in the business and they are fully accountable to shareholders . If they've lost so much shareholder value, they must be held accountable for the loss of shareholder value.

Grassroots shareholder activism is increasingly important in sending messages to management and whilst the ED investor forum is not an AGM, it is nonetheless a good opportunity to ask direct, probing questions and to expect direct answers.

The company's performance and responses at the investor presentation will no doubt subsequently be discussed here on these bulletin boards.


ALL IMO. DYOR.
QP

[ali47fish] 12/1/2017 18:49

TrOTTERS - we met at Angle- i'll be there too - look out for me-cheers

[daz] 12/1/2017 14:05

I'll be going along on the 25th as well.

[quepassa] 12/1/2017 13:29

Trotters.

Quite right.

Kindly also ask the CEO, Dr. Arnab Basu to clarify the precise status of the $159million contact.

No shilly-shallying, no avoiding answering, no evasive answers, no side-stepping the issue, no slippery-fish type answers.


Anyone who followed from the flotation has lost a real packet on Kromek.

In my opinion, Kromek have come nowhere near delivering on so many fronts.

I think they deserve a real grilling and support your initiatives.

Stand your ground and please try to pin them down on hard facts and concrete details .


Thanks.

QP

[chimers] 12/1/2017 13:11

Quite right.

[trotterstrading] 12/1/2017 12:55

Not to mention grilling him on his director buys.. or lack of them

[trotterstrading] 12/1/2017 12:54

I shall be asking the CEO directly on the 25th I shall also be telling him straight the share price performance since listing has been a horror story and asking him what he is doing to sort it out

[quepassa] 12/1/2017 11:24

Hi Culford,
happy New Year.

lots of "ifs" in that scenario.



ALL IMO. DYOR.
QP

[culford] 12/1/2017 11:08

2nd half normally better than 1st half and very good order book now. If a massive order comes in should be able to get finance to assist fulfilling it. It is v tight though and share price does not feel good. If they prove don't need cash this share should double v quickly though.

[2niffy] 12/1/2017 10:44

On the face of it cash burn significantly reduced.However flattered by receipt of £2.7m of year end debtors. These are big nos for a company with £8m ish t/o.

[chimers] 12/1/2017 09:59

If I held shares in this I'd be on the dog trying to get some answers.
Dont be frightened ,you employ them they work for you.
I see no reason why they wouldnt be happy to talk,their not doing well but they are at least a proper company trying to run a proper business.

[chimers] 12/1/2017 09:58

Why not ask them ?

[trotterstrading] 12/1/2017 09:52

2niffy, what garbage. KMK have spent the past 12 months scaling up its production facility. They are already geared up for big orders. CASH BURN IS DOWN! £1.5m in the half year results. £2.2m cash in the bank. If they do need cash and I think that's unlikely given broker comments, any raise will be on far more favourable terms than you espouse. They have a contracted £30m order book for security and much more to come

[2niffy] 12/1/2017 09:41

Company is burning through cash. Any significant order would require an increase in working cap, mobilisation costs etc which are not factored into brokers forecasts. Customer unlikely to place order without surety of companies financial strength. Refinancing required. Could be done in various ways but probably via institutional placing with private clients getting diluted out of sight. Their last fundraising at 25p a circ 30% discount to the then prevailing share price. Miton in strong position to dictate terms re financing and a lower share price strengthens their hand.

[chrisdgb] 12/1/2017 08:38

Would be nice to see the shrewd Miton topping up their holding at these levels..

[quepassa] 11/1/2017 21:17

yes, very convincing......"Tumps focus on homland"


let's be realistic, their sales are pretty microscopic and management do not convince in my opinion. Kromek have been back to the equity trough once or twice already and they have tested the faith of investors by issuing a shock warning on sales just a few months after flotation and now won't even give chapter and verse on their 4/4/14 RNS announcement about the mega $159million contract.

Where are the sales for the airport scanners, the medical imaging equipment which were so much spoken of? We hear repeatedly about a series of smallish contracts from Darpa for some cheap-to-buy handheld devices but what about the big ticket medical imaging equipment and the high-spec security scanning equipment. What about sales for that?

I personally can understand the share price slipping and the market becoming disenchanted. There is a big gulf in my opinion between the talk and the walk at Kromek.

Don't blame Amphion for share price weakness because if Kromek were so attractive, some institution would have bitten Amphion's arm off to acquire their full position.

Good luck all but carefully weigh reality against over zealous expectations.

ALL IMO. DYOR.
QP